Mediating effect of telomere length in a hypertension population exposed to cadmium: a case–control study

Q Yang, R Liu, Y Gao, H Kang, Z Zhang… - Journal of Human …, 2023 - nature.com
Cadmium (Cd) is associated with telomere length and hypertension, respectively, but the
mechanism behind its relationship is unclear. Our study aimed to clarify the role of telomere …

《 中国心血管健康与疾病报告2021》 关于中国高血压流行和防治现状

马丽媛, 王增武, 樊静, 胡盛寿 - 中国全科医学, 2022 - chinagp.net
随着社会经济的发展和人口老龄化, 城镇化进程的加速, 中国高血压患病率呈不断上升趋势,
特别是在农村地区. 高血压的知晓率, 治疗率和控制率虽有所提高, 但仍处于较低水平 …

Epidemiology of Hypertension in Asia

RG Sy, EJB Llanes, FER Punzalan… - … Disease in Asia, 2022 - Springer
Asia is the largest and most populous continent, with roughly 60% of the total population in
the world. It is divided into five regions, namely Middle East, East Asia, South Asia …

Interpretation of Report on Cardiovascular Health and Diseases in China 2023

LIU Mingbo, HE Xinye, Y Xiaohong, W Zengwu - J Clin Cardiol, 2024 - en.whuhzzs.com
The prevalence of cardiovascular disease (CVD) in China is on the rise. It is estimated that
there are 330 million people with CVD, including 13 million cases of stroke, 11.39 million …

The e-Health literacy among young and middle-aged hypertensive patients still needs improvement: a qualitative study

Z Mi, B Zhang, H Liu, H Hu, Y Huang - 2024 - researchsquare.com
Introduction: Although there is a marked trend of hypertension becoming increasingly
prevalent among younger age groups, young and middle-aged individuals are the primary …

Exploring Hypertension Incidence and Predictors in a Prospective Cohort Study of Kharameh in Southern Iran

A Rezaianzadeh, MG Johari, N Baeradeh, M Seif… - 2023 - researchsquare.com
Background: Hypertension (HTN) is a significant public health concern globally. The study
aims to estimate the incidence of HTN among adults aged 40 and above in southern Iran …

Interpretation of Report on Cardiovascular Health and Diseases in China 2023

M LIU, X HE, X YANG, Z WANG - Chinese General Practice - chinagp.net
The prevalence of cardiovascular disease (CVD) in China is on the rise. It is estimated that
there are 330 million people with CVD, including 13 million cases of stroke, 11.39 million …